tiprankstipranks
Trending News
More News >
MacroGenics (MGNX)
NASDAQ:MGNX
US Market

MacroGenics (MGNX) Financial Statements

Compare
657 Followers

MacroGenics Financial Overview

MacroGenics's market cap is currently $81.39M. The company's EPS TTM is $-1.075; its P/E ratio is ―; MacroGenics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.73. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 149.96M$ 58.75M$ 151.94M$ 75.64M$ 97.76M
Gross Profit$ 149.12M$ 50.53M$ 144.56M$ 72.99M$ -95.44M
Operating Income$ -110.58M$ -168.24M$ -121.42M$ -202.79M$ -131.06M
EBITDA$ -57.37M$ 2.02M$ -107.89M$ -190.86M$ -117.78M
Net Income$ -66.97M$ -9.06M$ -120.02M$ -190.86M$ -117.78M
Balance Sheet
Cash & Short-Term Investments$ 201.67M$ 229.81M$ 154.35M$ 243.62M$ 272.53M
Total Assets$ 261.65M$ 298.42M$ 280.47M$ 335.25M$ 378.74M
Total Debt$ 37.46M$ 33.97M$ 34.83M$ 25.47M$ 29.25M
Net Debt$ -145.38M$ -66.98M$ -74.05M$ -98.00M$ -151.88M
Total Liabilities$ 145.60M$ 145.81M$ 138.46M$ 95.63M$ 82.86M
Stockholders' Equity$ 116.06M$ 152.61M$ 142.01M$ 239.62M$ 295.88M
Cash Flow
Free Cash Flow$ -72.08M$ -79.97M$ -90.58M$ -150.03M$ -117.80M
Operating Cash Flow$ -68.37M$ -78.20M$ -86.96M$ -143.83M$ -111.90M
Investing Cash Flow$ 149.30M$ -80.08M$ 70.72M$ -36.61M$ -7.79M
Financing Cash Flow$ 960.00K$ 150.36M$ 1.66M$ 122.78M$ 174.34M
Currency in USD

MacroGenics Earnings and Revenue History

MacroGenics Debt to Assets

MacroGenics Cash Flow

MacroGenics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis